Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Anshi Pharmaceutical is a specialized pharmaceutical company focused on the research, development, and large-scale manufacturing of high-quality nutritional supplements and generic medications. The company is most recognized for its flagship calcium supplement brand, D-Cal (Di-Cal), which has achieved significant market share in China and other international markets. Operating with facilities that meet both US FDA and Chinese GMP standards, the company bridges Western pharmaceutical quality with global distribution capabilities. Its product portfolio spans across bone health, cardiovascular health, and metabolic diseases, providing both over-the-counter and prescription options. American Anshi maintains a strong presence in both the United States and China, leveraging its cross-border expertise to facilitate international pharmaceutical trade and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Anshi Pharmaceutical.